Europe

ePRO poised to get more user friendly as eClinicalHealth develops validation for BYOD

Monday, July 25, 2016

Sponsors and CROs are enthusiastic about the usefulness of handheld devices in clinical trials, which allow study subjects to input information in real time, rather than having all patient info stuffed into the patient’s meeting at the study site. Naturally, many companies are now in a race to make electronic patient-reported outcomes (ePRO) more user friendly. eClinicalHealth of Stirling, Scotland, has just pulled ahead.

[Read More]

Richter acquires Finox Holding for $185.2M

Friday, July 1, 2016

Gedeon Richter has announced the acquisition of Finox Holding, a privately held Swiss biotech company focused on development and commercialization of innovative and cost effective products addressing female fertility. Gedeon Richter, headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. 

[Read More]

EMA, FDA reinforce collaboration on patient engagement

Tuesday, June 28, 2016

The EMA and the FDA have set up a new ‘cluster’ on patient engagement. The cluster will provide a forum to share experiences and best practices on the way the two agencies involve patients in development, evaluation and post-authorization activities related to medicines.

[Read More]

Ombudsman calls for more transparency

Tuesday, June 14, 2016

The European Ombudsman, Emily O’Reilly, has welcomed increased transparency in the clinical testing of Humira, one of the world’s biggest selling drugs, following her inquiry into the publication of clinical study reports.

[Read More]

NIHR invests $23.4M in pediatrics research

Tuesday, May 31, 2016

A significant number of children experience long-term health conditions. This group’s health needs have not previously been given the research priority that they deserve. The NIHR has invested £21 million ($23.4 million) in 35 new studies focusing on improving the health outcomes for children and young people.

[Read More]